Conversely, a more recent study showed lower levels of CSF total α-synuclein and increased levels of oligomeric α-synuclein in LRRK2-NMC than HC, but similar levels compared with PD patients with and without LRRK2 variants [58]. This evidence concerns the gene LRRK2 and Parkinson disease.